NIH-funded research R01 grant

How trypsin becomes activated in pancreatitis

Official title: Mechanisms of Trypsin Activation in Pancreatitis

Funded at Boston University Medical Campus · NIH-11290323 · Data updated 2026-11-12

This project looks at how the digestive enzyme trypsin starts working inside the pancreas and how that can trigger pancreatitis in people with or at risk for the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 9, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$363,000
NIH project number5R01DK132471-04
Project IDNIH-11290323 on NIH RePORTER

Who could benefit from this research

Could help

People with recurrent or hereditary pancreatitis, a family history of pancreatitis, or known trypsinogen gene variants would be the most relevant candidates.

Less likely to help

Patients whose pancreatitis is caused solely by gallstones or alcohol without involvement of trypsin activation may not directly benefit from these findings.

What this research studies

The researchers will use animal models together with human genetic information to test three ways trypsinogen might become active inside the pancreas. They will compare activation caused by the enzyme cathepsin B with self-activation of trypsinogen that can happen when certain gene changes are present. By introducing specific genetic changes and altering cathepsin B activity, the team will track when pancreatitis begins, how severe it gets, and whether age of onset shifts. The work aims to clarify which activation pathway matters most under different genetic scenarios and will relate findings back to human disease.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or treat pancreatitis and help identify people at higher risk.

How similar studies have gone: Previous animal and human genetic studies have implicated both cathepsin B and trypsinogen autoactivation but have produced mixed results, so this work addresses an unresolved question.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Geisz-Fremy, Andrea — Boston University Medical Campus
  • Study coordinator: Geisz-Fremy, Andrea

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.